Side effects of immunosuppressant therapies used in neurology

Neurologic Clinics

Volumn 16, Issue 1, 1998, Pages 171-188

  Machkhas, H ^a   Harati, Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AZATHIOPRINE; CALCIUM; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETIDRONIC ACID; FOLIC ACID; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCORTISONE; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE; VITAMIN D;

ACUTE PANCREATITIS; AFFECTIVE NEUROSIS; ASEPTIC MENINGITIS; AUTOIMMUNITY; AVASCULAR NECROSIS; BLADDER CARCINOMA; BLOOD TOXICITY; BONE MARROW SUPPRESSION; BRAIN DISEASE; BRAIN INFARCTION; CATARACT; DRUG POTENTIATION; GASTROINTESTINAL SYMPTOM; GLUCOSE INTOLERANCE; HUMAN; HYPERSENSITIVITY; HYPERTENSION; IMMUNE DEFICIENCY; IMMUNOMODULATION; INTERSTITIAL PNEUMONIA; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MENSTRUAL IRREGULARITY; NEPHROTOXICITY; NEUROTOXICITY; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; PSYCHOSIS; RASH; REVIEW; SLEEP DISORDER;

EID: 0031891752     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(05)70373-X     Document Type: Article

References (151)

1. H. Abacioglu H. Okuyan Antibody to the human immunodeficiency virus in a commercial globulin preparation [letter] J Infect Dis 160 1989 161
2. J.D. Adachi W.G. Bensen J. Brown Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis N Engl J Med 337 1997 382
3. F. Aglas F. Rainer J. Herman Interstitial pneumonia due to cytomegalovirus following low-dose methotrexate treatment for rheumatoid arthritis Arthritis Rheum 38 1995 291
4. G.S. Alarcon M. Macaluso K. Singh Excess mortality in methotrexate-treated rheumatoid arthritis patients is not due to cancer or cardiovascular diseases [abstr] Arthritis Rheum 37 1994 S421
5. J.L. Allen G. Rosen Transiant cerebral dysfunction following chemotherapy for osteogenic sarcoma Ann Neurol 3 1978 441
6. M.T. Al-Lozi A. Pestronk W.C. Yee Rapidly evolving myopathy with myosin-deficient muscle fibers Ann Neurol 35 1994 273
7. Anonymous Outbreak of hepatitis C associated with intravenous immunoglobulin administration—United States, October 1993–June 1994 MMWR 43 1994 505
8. Anonymous The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis: Rheumatoid Arthritis Clinical Trial Archives Group J Rheumatol 22 1995 218
9. R.E. Appleton K. Farrell P. Teal Complex partial status epilepticus associated with cyclosporine A therapy J Neurol Neurosurg Psychiatry 52 1989 1068
10. F. Arrelano P. Krupp Muscular disorders associated with cyclosporine [letter] Lancet 337 1991 915
11. L. Axelrod Glucocorticoid therapy Medicine 55 1976 39
12. B.A. Baethge M.D. Lidsky Intractable hiccups associated with high-dose intravenous methylprednisolone therapy Ann Intern Med 104 1986 58
13. B.A. Baethge M.D. Lidsky J.W. Goldberg A study of adverse effects of high-dose intra venous (pulse) methylprednisolone therapy in patients with rheumatic disease Ann Pharmacother 26 1992 316
14. R.R. Bailey P. Armour Acute arthralgia after high-dose intravenous methylpredniso lone Lancet 2 1974 1014
15. B. Bannwarth L. Labat Y. Moride Methotrexate in rheumatoid arthritis: An update Drugs 47 1994 25
16. L.S. Belli De Carlis L. G.F. Romani Dysarthria and cerebellar ataxia: A late occurrence of severe neurotoxicity in a liver transplant recipient Transplant Int 6 1993 176
17. E. Ben-Chetrit C. Putterman Transient neutropenia induced by intravenous immune globulin [letter] N Engl J Med 326 1991 270
18. W.D. Blackburn G.S. Alarcon Impotence in three rheumatoid arthritis patients treated with methotrexate Arthritis Rheum 32 1989 1341
19. R. Blanco V.M. Martinez-Taboada M.A. Gonzalez-Gay Acute febrile toxic reaction in patients with refractory rheumatoid arthritis who are receiving combined therapy with methotrexate and azathioprine Arthritis Rheum 39 1996 1016
20. T.S. Bocanegra M.O. Castaneda L.R. Espinoza Sudden death after methylprednisolone pulse therapy [letter] Ann Intern Med 95 1981 122
21. T.H. Brannagan K.J. Nagle D.J. Lange Complications of intravenous immuneglobulin treatment in neurologic disease Neurology 47 1996 674
22. P. Bressler De Fronzo R.A. Drug effects on glucose homeostasis K.G.M.M. Alberti P. Zimmet R.A. De Fronzo International Textbook of Diabetes Mellitus ed 2 1997 John Wiley & Sons New York 213
23. P.G. Bullogh Di Carlo E.F. Subchondral avascular necrosis: A common cause of arthritis Ann Rheum Dis 49 1990 412
24. T.G. Cantu E.W. Hoehn-Saric K.M. Burgess Acute renal failure associated with immunoglobulin therapy Am J Kidney Dis 25 1995 228
25. C.M. Casserly K.C. Stange M.M. Chren Severe megaloblastic anemia in a patient receiving low-dose methotrexate for psoriasis J Am Acad Dermatol 29 1993 477
26. G.L. Chan D.M. Canafax C.A. Johnson The therapeutic use of azathioprine in renal transplantation Pharmacotherapy 7 1987 165
27. G. Chandran M.J. Ahern P.D. Hall Cirrhosis in patients with rheumatoid arthritis receiving low dose methotrexate Br J Rheumatol 33 1994 981
28. D. Chan-Lam E.J. Fitzsimmons W.S. Douglas Alopecia after immunoglobulin infusion [letter] Lancet 1 1987 1436
29. D. Chan-Lam A.G. Prentice J.A. Copplestone Avascular necrosis of bone following therapy for acute lymphoblastic leukemia and high-grade malignant lymphoma Br J Haematol 86 1994 227
30. G.A. Chrousos J.C. Kattah R.W. Beck Side effects of glucocorticoid treatment: Experience of the optic neuritis treatment trial JAMA 269 1993 2110
31. M.R. Cilio O. Danhaive J.F. Gadisseux Unusual cyclosporine-related neurological complications in recipients of liver transplants Arch Dis Child 68 1993 405
32. C. Confavreux P. Saddier J. Grimaud Risk of cancer from azathioprine therapy in multiple sclerosis: A case control study Neurology 46 1996 1607
33. H.O. Conn B.L. Blitzer Nonassociation of adrenocorticosteroid therapy and peptic ulcer N Engl J Med 294 1976 473
34. W.R. Connell M.A. Kamm M. Dickson Long-term neoplasia after azathioprine treatment in inflammatory bowel disease Lancet 343 1994 1249
35. W.R. Connell M.A. Kamm J.K. Ritchie Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience Gut 34 1993 1081
36. N.J. Cook G.J. Caroll Successful reintroduction of methotrexate after pneumonitis in two patients with rheumatoid arthritis Ann Rheum Dis 51 1992 272
37. R.L. Cruess Cortisone induced avascular necrosis of the femoral head J Bone Joint Surg 59 1972 308
38. J.J. Curtis J.H. Galla S.Y. Woodford Comparison of daily and alternate-day prednisone during chronic maintenance therapy: A controlled cross-over study Am J Kidney Dis 1 1981 166
39. M. Dalakas Pharmacologic concerns of corticosteroids in the treatment of patients with immune related neuromuscular diseases Neurol Clin 8 1990 93
40. M.C. Dalakas High-dose intravenous immunoglobulin and serum viscosity: Risk of precipitating thromboembolic events Neurology 44 1994 223
41. De Groen P.C. A.J. Aksamit J. Rakela Central nervous system toxicity after liver transplantation: The role of cyclosporine and cholesterol N Engl J Med 317 1987 861
42. T. Diamond L. McGuigan S. Barbagallo Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in post-menopausal women Am J Med 98 1995 459
43. M.D. Efros T. Ahmed N. Coombe Urologic complications of high-dose chemotherapy and bone marrow transplantation Urology 43 1994 355
44. R.J. Ellis M.R. Swendson J. Bajorek Aseptic meningitis as a complication of intravenous immunoglobulin therapy for myasthenia gravis Muscle Nerve 17 1994 683
45. W.K. Engel A. Borenstein De Vivo D.C. High single-dose alternate-day prednisone (HSDAD-PRED) in treatment of dermatomyositis/polymyositis complex Trans Am Neurol Assoc 97 1972 272
46. A.S. Fauci Alternate-day corticosteroid therapy Am J Med 64 1978 729
47. G. Feutren M.J. Mihatsch Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases: International kidney biopsy registry of cyclosporine in autoimmune diseases N Engl J Med 326 1992 1654
48. M.J. Fordyce L. Solomon Early detection of avascular necrosis of the femoral head by MRI J Bone Joint Surg (Br) 75 1993 365
49. U. Frei V. Bode H. Repp Malignancies under cyclosporine after kidney transplantation: Analysis of a 10-year period Transplant Proc 25 1993 1394
50. S.T.F.M. Frequin K.J.B. Lamers F. Barkhof Follow-up study of multiple sclerosis patients treated with high-dose intravenous methylprednisolone Acta Neurol Scand 90 1994 105
51. R.G. Gagliano J.J. Costanzi Paraplegia following intrathecal methotrexate Cancer 37 1976 1663
52. A. Genge G. Karpati Intermittent, high-dose, intravenous glucocorticoid (GC) treatment is preferred to high-dose oral GC administration in adult dermatomyositis [abstr] Neurology 48 1997 A321
53. R.M. Graham Cyclosporine: Mechanisms of action and toxicity Cleve Clin J Med 61 1994 308
54. J.A. Greeves Rapid onset steroid psychosis with very low dosage prednisolone [letter] Lancet 1 1984 1119
55. C. Guzzo Folic acid supplementation with methotrexate therapy: What benefit if any? [letter] J Am Acad Dermatol 31 1994 689
56. R.C.W. Hall M.K. Popkin S.K. Stickney Presentation of steroid psychosis J Neurol Ment Dis 167 1979 229
57. S.S. Haplea J.T. Farrar G.A. Gibson Thromboembolic events associated with intravenous immunoglobulin therapy Neurology 48 1997 A54
58. R.U. Hausknecht Methotrexate and misoprostol to terminate early pregnancy N Engl J Med 333 1995 537
59. Hauser W.J. Jr N.S. Swack M.T. Ramirez Additional commercial gammaglobulin preparations found with antibody to human immunodeficiency virus [letter] J Infect Dis 161 1990 153
60. M. Hirano B.R. Ott E.C. Raps Acute quadriplegic myopathy: A combination of treatment with steroids, nondepolarizing blocking agents, or both Neurology 42 1992 2082
61. J.R. Hoover J.F. Fraumeni Risk of cancer in renal transplant recipients Lancet 2 1973 55
62. L.L. Ioannides N. Christophidis P. Ryan Dosing implications of a clinical interaction between grapefruit juice and cyclosporine and metabolite concentrations in patients with autoimmune diseases J Rheumatol 24 1997 49
63. N. Jaffe Transient neurological disturbance induced by high dose methotrexate treatment Cancer 56 1985 1356
64. M.E. Jeurissen A.M. Boerbooms L.B. Van de Putte Azathioprine induced fever, chills, rash and hepatotoxicity in rheumatoid arthritis Ann Rheum Dis 49 1990 25
65. D.A. Joyce R.K. Will D.L. Hoffman Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid Ann Rheum Dis 50 1991 913
66. G.C. Kane M.B. Troshinsky S.P. Peters Pneumocystis carinii pneumonia associated with weekly methotrexate: Cumulative dose of methotrexate and low CD4 cell count may predict this complication Respir Med 87 1993 153
67. J.G. Kaplan E. Barasch A. Hirschfeld Spinal epidural lipomatosis: A serious complication of iatrogenic Cushing's syndrome Neurology 39 1989 1031
68. S.R. Kaplan P. Calabresi Immunosuppressive agents N Engl J Med 289 1973 1234
69. P.A. Keenan M.A. Jacobson M.A. Soleymani The effect on memory of chronic prednisone treatment in patients with systemic disease Neurology 47 1996 1396
70. L.J. Kinlen Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment Am J Med 78 suppl 1985 44
71. L.J. Kinlen A.G. Sheil J. Peto Collaborative United Kingdom–Australasian study of cancer in patients treated with immunosuppressive drugs BMJ 2 1979 1461
72. D.J. Knusek Mc Lean J.A. W.R. Solomon Immediate hypersensitivity reaction to cyclophosphamide Arthritis Rheum 37 1994 1101
73. J.M. Kremer G.S. Alarcon R.W. Lightfoot Methotrexate for rheumatoid arthritis: Suggested guidelines for monitoring liver toxicity: American College of Rheumatology Arthritis Rheum 37 1994 316
74. J.K. Lacki W. Samborski S.H. Machiewicz Transient increase of aminotransferases in RA patients treated with methotrexate Z Rheumatol 52 1993 232
75. D. Lacomis M.J. Giuliani Van Cott A. Acute myopathy of intensive care: Clinical, electromyographic, and pathological aspects Ann Neurol 40 1996 645
76. J. Lear R.G. Daniels Muscle cramps related to corticosteroids [letter] BMJ 306 1993 1169
77. G.P. Lemense S.A. Sahn Opportunistic infection during treatment with low dose methotrexate Am J Respir Crit Care Med 150 1994 258
78. L.A. Levine D.F. Jarrard Treatment of cyclophosphamide-induced hemorrhagic cystitis with intravesicular carbaprost tromethamine J Urol 149 1993 719
79. Le Witt P.A. N.W. Barrow J.B. Posner Hiccup with dexamethasone therapy Ann Neurol 12 1982 405
80. Lo Cascio V. E. Bonucci B. Imbibo Bone loss in response to long-term glucocorticoid therapy Bone Miner 8 1990 39
81. V.P. Lucas T.D. Ponge M.L. Plougastel-Lucas Musculoskeletal pain in renal transplant recipients N Engl J Med 325 1991 1449
82. R.G. Luke Mechanism of cyclosporine-induced hypertension Am J Hyperten 4 1991 468
83. B.P. Lukert B.E. Johnson R.G. Robinson Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss J Bone Miner Res 7 1992 1063
84. P.R. Lyons P.K. Newman M. Saunders Methylprednisolone therapy in multiple sclerosis: A profile of adverse effects J Neurol Neurosurg Psychiatry 51 1988 285
85. H. Machkhas Y. Harati Pulse intravenous methylprednisolone (IVMP) in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) [abstr] Neurology 48 1997 A87 A88
86. M. McMahon J. Gerich R. Rizza Effect of glucocorticoids on carbohydrate metabolism Diabetes Metab Rev 4 1988 17
87. R.P. McManus D.P. O'Hair J. Schweiger Cyclosporine-associated central neurotoxicity after heart transplantation Ann Thorac Surg 53 1992 326
88. R.M. McNamara Anaphylaxis after intravenous corticosteroid administration J Emerg Med 4 1986 213
89. L.M. Mendelson E.D. Meltzer R.N. Hamburger Anaphylaxis-like reactions to corticosteroid therapy J Allergy Clin Immunol 54 1974 125
90. J. Messer D. Reitman H.S. Sacks Association of adrenocorticosteroid therapy and peptic ulcer disease N Engl J Med 309 1983 21
91. M.J. Mihatsch K. Wolff Report of a meeting: Consensus conference on cyclosporine A for psoriasis Br J Dermatol 126 1992 621
92. L.J. Miller S.W. Chandler C.M. Ippoliti Treatment of cyclophosphamide-induced hemorrhagic cystitis with prostaglandins Ann Pharmacother 28 1994 590
93. S.A. Misbah H.M. Chapel Adverse effects of intravenous immunoglobulin Drug Saf 9 1993 254
94. M. Mitterer N. Pescosta W. Vogetseder Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura [letter] Ann Hematol 67 1993 151
95. C. Modesto L. Castro Folinic acid supplementation in patients with juvenile rheumatoid arthritis treated with methotrexate J Rheumatol 23 1996 403
96. S.L. Morgan J.E. Baggot W.H. Vaughn The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis Arthritis Rheum 33 1990 9
97. R.D. Moses A. McCormick W. Nickey Fatal arrhythmia after pulse methylprednisolone therapy [letter] Ann Intern Med 95 1981 781
98. E.D. Newman T.M. Harrington Fatal methotrexate pneumonitis in rheumatoid arthritis Arthritis Rheum 31 1988 1585
99. K.J. Newmark S. Mitra L.B. Berman Acute arthralgia following high-dose intravenous methylprednisolone therapy Lancet 2 1974 229
100. G. Papa A. Bianchi F.R. Mauro Cyclosporine-associated bilateral deltoid paralysis after bone marrow transplantation for chronic myelogenous leukemia Haematologica 70 1985 273
101. L. Paserchia J. Welsberg D. George Methotrexate may lower seizure threshold in patients with epilepsy [letter] J Rheumatol 19 1992 998
102. A.B. Pathak S.H. Advani R. Gopal Urinary bladder cancer following cyclophosphamide therapy for Hodgkin's disease Leuk Lymphoma 8 1972 503
103. C.A. Philips P.J. Cera T.F. Mangan Clinical liver disease in patients with rheumatoid arthritis taking methotrexate J Rheumatol 19 1992 229
104. J.M. Piper W.A. Ray J.R. Daugherty Corticosteroid use and peptic ulcer disease: Role of non-steroidal anti-inflammatory drugs Ann Intern Med 114 1991 735
105. P. Poullin B. Moulin J. Ollier Renal complications from intravenous immunoglobulins: Role of renal hemodynamic factors Presse Med 24 1995 441
106. G. Queffeulou D. Ducloux C. Faucher Fatal cyclophosphamide-induced interstitial pneumonitis in a renal transplant patient Nephrol Dial Transplant 9 1994 1655
107. D.E. Reece D.A. Frei-Lahr J.D. Shepherd Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin Bone Marrow Transplant 8 1991 393
108. B. Ritters B. Grabensee P. Heering Malignancy under immunosuppressive therapy including cyclosporine Transplant Proc 26 1994 2656
109. O. Robain O. Dulac J.P. Dommergues Necrotizing leukoencephalopathy complicating treatment of childhood leukemia J Neurol Neurosurg Psychiatry 47 1984 65
110. L.J. Rubenstein M.M. Herman R.F. Long Disseminated necrotizing leukoencephalopathy: A complication of treated central nervous system leukemia and lymphoma Cancer 35 1975 291
111. A.M. Rubin H. Kang Cerebral blindness and encephalopathy with cyclosporin A toxicity Neurology 37 1987 1072
112. M. Ruggeri G. Castaman De Nardi G. Acute renal failure after high-dose intravenous immunoglobulin in a patient with idiopathic thrombocytopenic purpura Haematologica 78 1993 338
113. J.H. Saiki S. Thompson F. Smith Paraplegia following intrathecal chemotherapy Cancer 29 1972 370
114. D.M. Sandoval G.S. Alarcon S.L. Morgan Adverse events in methotrexate-treated rheumatoid arthritis patients Br J Rheumatol 34 suppl 1995 49
115. M.W. Savage C.P. Raguran S. Rogers High dose intravenous methotrexate and reversible focal neurologic deficit Br J Haematol 76 1990 558
116. E.A. Schaff U. Penmetsa S.H. Eisinger Methotrexate: A single agent for early abortion J Reprod Med 42 1997 56
117. C. Schiavotto M. Reggeri F. Rodeghiero Adverse reactions after high-dose intravenous immunoglobulin: Incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of literature Haematologica 78 1993 35
118. K.O. Schowengerdt R.J. Gajarski S. Denfield Progressive visual deterioration leading to blindness after pediatric heart transplantation Tex Heart Inst J 20 1993 299
119. E. Schutz J. Gummert F.W. Mohr Azathioprine myelotoxicity related to elevated 6-thioguanine nucleotides in heart transplantation Transplant Proc 27 1995 1298
120. T.L. Schwinghammer L.E. Wiggins M.R. Burgunder Adverse reaction to IV infusion of high-dose cyclophosphamide in bone marrow transplant patients Am J Hosp Pharm 51 1994 2419
121. E.A. Sekul E.J. Cupler M.C. Dalakas Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: Frequency and risk factors Ann Intern Med 121 1994 259
122. M.Z. Shi S.F. Zhang Steroid diabetes: An analysis of 28 years Chin J Intern Med 28 1985 139
123. J.O. Sieck Y. Al-Ohaly J. Saour An allergic reaction to intravenous methylprednisolone administration Br J Clin Pract 44 1990 723
124. P.L. Silbert W.V. Knezevic D.T. Bridge Cerebral infarction complicating intravenous immunoglobulin therapy for polyneuritis cranialis Neurology 42 1992 257
125. L.S. Snyder R.I. Heigh M.L. Anderson Cyclophosphamide-induced hepatotoxicity in a patient with Wegener's granulomatosis Mayo Clin Proc 68 1993 1203
126. R.E. Steg E.G. Garcia Complex visual hallucinations and cyclosporine neurotoxicity Neurology 41 1991 1156
127. R.E. Steg D.M. Lefkowitz Cerebral infarction following intravenous immunoglobulin therapy for myasthenia gravis Neurology 44 1994 1180
128. K.A. Stewart A.H. Mackenzie J.D. Clough Folate supplementation in methotrexate-treated rheumatoid arthritis Semin Arthritis Rheum 20 1991 332
129. A. Struys A.A. Snelder H. Mulder Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid induced osteoporosis Am J Med 99 1995 235
130. C. Talar-Williams M.C. Sneller Complications of corticosteroid therapy Eur Arch Otorhinolaryngol 251 1994 131
131. G. Taliani E. Guerra R. Rosso Hepatitis C virus infection in hypogammaglobulinemic patients receiving long term replacement therapy with intravenous immunoglobulin Transfusion 35 1995 103
132. E. Tan M. Hajinazarian W. Bay Acute renal failure resulting from intravenous immunoglobulin therapy Arch Neurol 50 1993 137
133. E. Thomas J.L. Leroux F. Blotman Gynecomastia in patient with rheumatoid arthritis treated with methotrexate J Rheumatol 21 1994 1777
134. E. Thomas J.L. Leroux J.P. Hellier Seizure and methotrexate therapy in rheumatoid arthritis [letter] J Rheumatol 20 1993 1632
135. G.W. Thorn Clinical considerations in the use of corticosteroids N Engl J Med 274 1966 775
136. M. Tishier D. Caspi B. Fishel The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis Arthritis Rheum 31 1988 906
137. R. Torricelli S.B. Kurer T. Kroner Delayed allergic reaction to chlorambucil (leukeran): Case report and literature review [in German] Schweiz Med Wochenschr 125 1995 1870
138. L.B. Travis R.E. Curtis B. Glimelius Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma J Natl Cancer Inst 87 1995 524
139. Venkat Raman G. V.L. Sharman H.A. Lee Azathioprine and allopurinol: A potentially dangerous combination J Intern Med 228 1990 69
140. M. Vera-Ramirez M. Charlet G.J. Parry Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy Neurology 42 1992 1636
141. J.M. Vose E.C. Reed G.C. Pippert Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: A randomized trial J Clin Oncol 11 1993 1306
142. A.E. Walker J.S. Adamkiewicz Pseudotumor cerebri associated with prolonged corticosteroid therapy JAMA 188 1964 779
143. R.W. Walker J.C. Allen G. Rosen Transient cerebral dysfunction secondary to high dose methotrexate J Clin Oncol 4 1986 1845
144. R.W. Walker J.A. Brochstein Neurologic complications of immunosuppressive agents Neurol Clin 6 1988 261
145. P.H. Wasserstein L.S. Honig Parkinsonism during cyclosporine treatment Bone Marrow Transplant 18 1996 649
146. T.J. Williams R.E. O'Hehir D. Czamy Acute myopathy in severe acute asthma treated with intravenously administered corticosteroids Am Rev Respir Dis 137 1988 460
147. F.H. Wolfhagen H.R. Van Buuren den Ouden J.W. Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis: A prospective, controlled pilot study J Hepatol 26 1997 325
148. 2alpha Hinyokika Kiyo 40 1994 833
149. P.L. Yap F. McOmish A.D. Webster Hepatitis C virus transmission by intravenous immunoglobulin J Hepatol 21 1994 455
150. G.C. Yee D.C. Stanley L.J. Pessa Effect of grapefruit juice on blood cyclosporine concentration Lancet 345 1995 955
151. K. Yoshimoto A. Hisamoshi H. Ogata Urinary bladder carcinoma was induced in a patient treated with cyclophosphamide for malignant lymphoma [in Japanese] Rinsho Ketsueki 35 1994 300